top of page

The New Era of Healthcare Begins in Childhood

Healthcare has historically been built around adult medicine, with pediatric care too often relying on therapies developed for adults. 

 

We believe the greatest healthcare companies of the next decade will intervene earlier- preventing, detecting, and fundamentally altering disease before lifelong consequences emerge.

 

Advances in AI, multiomics, precision medicine and maternal-fetal medicine are making that possible in ways that did not exist a decade ago. 

​

 

 

​

​​

​​

Science has moved upstream.

Venture capital has not.​

1 in 3

children live with a chronic condition

1 in 12

mothers lack access to care

1 in 2

pediatric prescriptions are off label

Pediatric and maternal health represent a $460 B market serving nearly 25% of the U.S. population, yet historically attract less than 1% of venture capital.

​​

​

 

Pediatrics is fundamentally different from adult medicine.

​

Its biology, clinical development, regulatory pathways, and commercialization require specialized expertise, creating barriers that have historically limited investment despite the market's scale.

​

 

 

 

The disconnect is evident across the pediatric care continuum:​​​​​

​​

​​​​Earlier intervention improves outcomes.

Earlier investment builds category leaders.

SAN FRANCISCO, CA, USA  |

fractal@4pedcapital.com    |

© All Rights Reserved 2026

Fractal Pediatric Capital (FPC) is a website operated by Fractal Pediatric Capital, LLC. By accessing this site and any pages hereof, you agree to be bound by the Terms of Service. FPC does not make investment recommendations, and no communication through this website or otherwise should be construed as a recommendation for any offer of a security referenced on this website or otherwise. Companies or individuals providing information on this site are solely responsible for their content. All investors in FPC Funds must be accredited investors. Investing in private placements requires high tolerance for risk and illiquidity, and investors must be able to afford to lose their entire investment. Information about any securities offering should not be considered complete and is qualified by the full offering documents corresponding to the financing. The information contained here or in any correspondence or attachment hereto may include forward-looking statements, estimates, projections and/or representations. To the fullest extent permissible by law, neither FPC, LLC. nor its funds; nor any of their managers or non-managing members, employees, representatives, or agents make any representation or warranty, express or implied, as to the accuracy, completeness or definitiveness of this information, and nothing contained herein shall be relied upon as a representation as to past or future performance. We are not a registered broker, dealer, investment advisor, investment manager or funding portal. FPC, LLC and FPC Managing Member do not give investment advice, provide analysis or recommendations. *IRS Circular 230 Disclosure: To ensure compliance with requirements imposed by the IRS, we inform you that any tax advice contained in this communication (including any attachments) was not intended or written to be used and cannot be used, for the purpose of (i) avoiding any tax penalty or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein.

bottom of page